EPIGRAL LIMITED
EPIGRAL · Chemicals · NSE
₹1,127
Current Market Price
Fair Value (DCF)
₹1,250
Discount to FV
+10.9%
Updated 8h ago
YieldIQ Score
35/100
Piotroski F-Score
3/9
Economic Moat
None
Confidence
44%
ROE
14.9%
Debt/Equity
0.26
WACC
11.1%
Market Cap
₹4,861 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
19.9%
Return on capital employed
EV / EBITDA
10.5×
Enterprise multiple
Debt / EBITDA
1.0×
Leverage vs earnings
Interest Coverage
13.7×
EBIT covers interest
Current Ratio
1.57×
Short-term liquidity
Asset Turnover
0.83×
Revenue per ₹ of assets
Revenue CAGR (3Y)
4.8%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,126.8
Bear case
Discount -43.0%
Base case
Discount +9.8%
Bull case
Discount +38.9%
Ratio Trends
EPIGRAL · last 5 annual periods
ROE
14.9%
ROCE
19.9%
Operating Margin
—
Debt / Equity
0.26×
PE
—
EV / EBITDA
—
Historical Financials
EPIGRAL · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹1550 Cr | ₹2169 Cr | ₹1894 Cr | ₹2514 Cr | ₹2495 Cr | +12.6% |
| EBITDA | ₹501 Cr | ₹681 Cr | ₹477 Cr | ₹716 Cr | ₹556 Cr | +2.6% |
| EBIT | ₹428 Cr | ₹588 Cr | ₹364 Cr | — | — | -3.9% |
| PAT | ₹253 Cr | ₹353 Cr | ₹196 Cr | ₹358 Cr | ₹332 Cr | +7.0% |
| EPS (diluted) | ₹60.84 | ₹85.03 | ₹47.13 | — | — | -6.2% |
| CFO | ₹284 Cr | ₹626 Cr | ₹398 Cr | ₹441 Cr | ₹436 Cr | +11.3% |
| CapEx | ₹-456 Cr | ₹-416 Cr | ₹-398 Cr | ₹-195 Cr | ₹-394 Cr | — |
| FCF | ₹-172 Cr | ₹210 Cr | ₹-0.8 Cr | ₹246 Cr | ₹41.4 Cr | — |
| Total Assets | ₹2124 Cr | ₹2432 Cr | ₹2794 Cr | ₹3152 Cr | ₹3505 Cr | +13.3% |
| Total Debt | ₹782 Cr | ₹769 Cr | ₹909 Cr | ₹593 Cr | ₹572 Cr | -7.5% |
| Shareholders' Equity | ₹726 Cr | ₹1069 Cr | ₹1254 Cr | ₹1905 Cr | ₹2221 Cr | +32.3% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
EPIGRAL vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
GUJALKALI GUJALKALI | — | — | Pending | -0.0% | — |
 INDIAGLYCO INDIAGLYCO | — | — | Pending | 10.0% | 19.4× |
 GNFC GNFC | — | — | Pending | 8.9% | 6.7× |
ACI ACI | — | — | Pending | 5.5% | — |
 DEEPAKFERT DEEPAKFERT | — | — | Pending | 10.8% | — |
Click a ticker to view its fair-value analysis.
Dividend History
4 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹16.00/sh
Last payout
2026-06-01
₹5.00
Peak payout
₹5.00
Trailing yield
0.75%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. EPIGRAL LIMITED (EPIGRAL.NS) trades at 1126.80 vs a model fair value of 1249.62, a gap of 10.9%. Piotroski F-score: 3/9. Moat label: None...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of EPIGRAL →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for EPIGRAL →
Compare
Head-to-head with peers
Compare EPIGRAL side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse EPIGRALNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.